I’ll admit to being surprised initially by the mid-month announcement that Regeneron Pharmaceuticals planned to buy out of ...

Anne Wojcicki's last stand for 23andMe? The cofounder and former CEO plans to object to its sale to Regeneron through a ...

Grill season is heating up, and for most Americans, cookouts are the crown jewel of an array of summer activities.Whether ...

Human genetics testing firm 23andMe announced Tuesday it will voluntarily delist from the Nasdaq and deregister with the U.S.

Genetic testing company 23andMe had 15 million consumers who turned to them to learn more about their ancestry and understand ...

Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

Regeneron (NASDAQ: REGN) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous ...

Republican senators John Cornyn and Chuck Grassley and Democratic Sen. Amy Klobuchar are rolling out a bipartisan measure to protect sensitive genetic data in response to privacy concerns sparked by ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented on the recent downgrade of US credit. In a surprising development that led markets to end flat during ...

Braskem is considering expanding its ethylene cracker and polyethylene complex in the Brazilian state of Rio de Janeiro by ...